Oxford Nanopore Technologies plc (LON:ONT – Get Free Report)’s share price dropped 0.2% on Tuesday . The company traded as low as GBX 134.10 and last traded at GBX 142.97. Approximately 1,983,077 shares traded hands during trading, a decline of 80% from the average daily volume of 9,874,966 shares. The stock had previously closed at GBX 143.20.
Wall Street Analyst Weigh In
Separately, Royal Bank Of Canada reaffirmed an “outperform” rating and set a GBX 225 target price on shares of Oxford Nanopore Technologies in a report on Tuesday, May 26th. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of GBX 218.60.
Check Out Our Latest Stock Report on ONT
Oxford Nanopore Technologies Stock Up 0.7%
Oxford Nanopore Technologies (LON:ONT – Get Free Report) last issued its quarterly earnings results on Monday, March 2nd. The company reported GBX (15.10) EPS for the quarter. Oxford Nanopore Technologies had a negative return on equity of 29.43% and a negative net margin of 64.85%.
Insider Activity at Oxford Nanopore Technologies
In other news, insider Nick Keher sold 22,993 shares of the stock in a transaction on Tuesday, April 14th. The shares were sold at an average price of GBX 108, for a total value of £24,832.44. Over the last 90 days, insiders have acquired 22,678 shares of company stock valued at $2,563,129. 2.33% of the stock is owned by corporate insiders.
Oxford Nanopore Technologies Company Profile
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Further Reading
- Five stocks we like better than Oxford Nanopore Technologies
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
